» Articles » PMID: 30863087

Metabolic Reprogramming Results in Abnormal Glycolysis in Gastric Cancer: a Review

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2019 Mar 14
PMID 30863087
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The Warburg effect in tumor cells involves the uptake of high levels of glucose, enhanced glycolysis, and the metabolism of pyruvate to lactic acid rather than oxidative phos-phorylation to generate energy under aerobic conditions. This effect is closely related to the occurrence, invasion, metastasis, drug resistance, and poor prognosis of gastric cancer (GC). Current research has further demonstrated that the Warburg effect in GC cells is not only mediated by the glycolysis pathway, but also includes roles for mitochondria, noncoding RNAs, and other proteins that do not directly regulate metabolism. As a result, changes in the glycolysis pathway not only lead to abnormal glucose metabolism, but they also affect mitochondrial functions, cellular processes such as apoptosis and cell cycle regulation, and the metabolism of lipids and amino acids. In this review, we discuss metabolic reprogramming in GC based on glycolysis, a possible link between glucose metabolism, lipid metabolism, and amino acid metabolism, and we clarify the role of mitochondria. We also examine recent studies of metabolic inhibitors in GC.

Citing Articles

Total cardiolipin levels in gastric and colon cancer: evaluating the prognostic potential.

Dimitrijevs P, Freiliba I, Pcolkins A, Leja M, Arsenyan P Lipids Health Dis. 2025; 24(1):76.

PMID: 40016755 PMC: 11866619. DOI: 10.1186/s12944-025-02499-5.


Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolism.

Tsai H, Tsai K, Wu D, Huang Y, Lin M Stem Cell Res Ther. 2025; 16(1):87.

PMID: 39988680 PMC: 11849191. DOI: 10.1186/s13287-025-04223-7.


Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.

Chen Z, Yu T, Wang Y, Li J, Zhang B, Zhou L Front Oncol. 2025; 14:1443686.

PMID: 39906672 PMC: 11790455. DOI: 10.3389/fonc.2024.1443686.


CircRNAs: A promising target for intervention regarding glycolysis in gastric cancer.

Dai Q, Liu Y, Ding F, Guo R, Cheng G, Wang H Heliyon. 2025; 10(14):e34658.

PMID: 39816354 PMC: 11734058. DOI: 10.1016/j.heliyon.2024.e34658.


Identification of gastric cancer subtypes based on disulfidptosis-related genes: GPC3 as a novel biomarker for prognosis prediction.

Yi N, Yin X, Feng X, Ren M, Ma C Discov Oncol. 2024; 15(1):810.

PMID: 39695020 PMC: 11655940. DOI: 10.1007/s12672-024-01694-7.


References
1.
Pastorino J, Shulga N, Hoek J . Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2001; 277(9):7610-8. DOI: 10.1074/jbc.M109950200. View

2.
Sugano K, Sato K, Yao K . New diagnostic approaches for early detection of gastric cancer. Dig Dis. 2005; 22(4):327-33. DOI: 10.1159/000083594. View

3.
Lee H, Yin P, Lin J, Wu C, Chen C, Wu C . Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005; 1042:109-22. DOI: 10.1196/annals.1338.011. View

4.
Feksa L, Cornelio A, Dutra-Filho C, de Souza Wyse A, Wajner M, Duval Wannmacher C . The effects of the interactions between amino acids on pyruvate kinase activity from the brain cortex of young rats. Int J Dev Neurosci. 2005; 23(6):509-14. DOI: 10.1016/j.ijdevneu.2005.06.002. View

5.
Kamalidehghan B, Houshmand M, Ismail P, Panahi M, Akbari M . Delta mtDNA4977 is more common in non-tumoral cells from gastric cancer sample. Arch Med Res. 2006; 37(6):730-5. DOI: 10.1016/j.arcmed.2006.02.005. View